Dechert Antitrust Merger Investigation Reports Record Duration of U.S. Merger Investigations in 2015
Significant antitrust merger investigations in the United States took an average of 9.6 months in 2015, more than a third longer than the average...
322 Views
Healthcare Observer: As Long-Term Patent Exposure Ebbs, Innovation in Big Pharma Pipelines Support
Pipeline innovation outpacing patent losses represents a core element of the wide moat ratings for most of the Big Pharma firms. Slowing patent...
327 Views
Morningstar Healthcare Observer: Biotech Industry Undervalued
The median price/fair value in our biotech universe is 0.87, and in late September valuations fell to their cheapest levels since 2011. While this...
291 Views
SoulCycle IPO - Good for your portfolio and your soul?
"Dance party on a bike" - that's how the founders of SoulCycle like to describe their business. SoulCycle is a lifestyle and fitness brand that...
255 Views
Biosimilars Seen Fueling Next Wave of Pharma Deals
Pharma and biotech mergers look set to continue apace as players reposition within the industry, especially on the generics side.. Biosimilars are...
271 Views